Preclinical assessment of abuse liability of biologics: In defense of current regulatory control policies
- 1 October 2015
- journal article
- review article
- Published by Elsevier in Regulatory Toxicology and Pharmacology
- Vol. 73 (1) , 43-54
Abstract
No abstract availableKeywords
This publication has 122 references indexed in Scilit:
- Circadian rhythms, sleep, and substance abuseSleep Medicine Reviews, 2012
- Testosterone as a discriminative stimulus in male ratsPharmacology Biochemistry and Behavior, 2011
- Dissimilar cannabinoid substitution patterns in mice trained to discriminate Δ9-tetrahydrocannabinol or methanandamide from vehicleBehavioural Pharmacology, 2011
- Anticonflict and Reinforcing Effects of Triazolam + Pregnanolone Combinations in Rhesus MonkeysThe Journal of Pharmacology and Experimental Therapeutics, 2011
- The endogenous cannabinoid anandamide shares discriminative stimulus effects with ∆9-tetrahydrocannabinol in fatty acid amide hydrolase knockout miceEuropean Journal of Pharmacology, 2011
- Tolerance to allopregnanolone with focus on the GABA‐A receptorBritish Journal of Pharmacology, 2010
- Reinforcing and neurochemical effects of cannabinoid CB1 receptor agonists, but not cocaine, are altered by an adenosine A2A receptor antagonistAddiction Biology, 2010
- FAAH−/− Mice Display Differential Tolerance, Dependence, and Cannabinoid Receptor Adaptation After Δ9-Tetrahydrocannabinol and Anandamide AdministrationNeuropsychopharmacology, 2010
- Illicit gamma-hydroxybutyrate (GHB) and pharmaceutical sodium oxybate (Xyrem®): Differences in characteristics and misuseDrug and Alcohol Dependence, 2009
- Discovery and Characterization of a Highly Selective FAAH Inhibitor that Reduces Inflammatory PainChemistry & Biology, 2009